| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.275.14.10308 |
| P8608 | Fatcat ID | release_buobp3lscbdabl7vzjwdknmazu |
| P3181 | OpenCitations bibliographic resource ID | 693906 |
| P698 | PubMed publication ID | 10744718 |
| P2093 | author name string | S Kumar | |
| P C McDonnell | |||
| P R Young | |||
| M L Doyle | |||
| R Tal-Singer | |||
| D E Griswold | |||
| M N Tzimas | |||
| L Tierney | |||
| E A Capper | |||
| R Lehr | |||
| G I Wells | |||
| P2860 | cites work | Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain | Q22001492 |
| Cloning of a novel receptor subunit, AcPL, required for interleukin-18 signaling | Q22004163 | ||
| Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response | Q22008772 | ||
| Structural basis for FGF receptor dimerization and activation | Q22010544 | ||
| A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types | Q24309431 | ||
| Purification and characterization of the human interleukin-18 receptor | Q24316885 | ||
| Cloning of a cDNA encoding a novel interleukin-1 receptor related protein (IL 1R-rp2) | Q24317663 | ||
| A family of human receptors structurally related to Drosophila Toll | Q24321888 | ||
| Molecular cloning of the interleukin-1 beta converting enzyme | Q24338607 | ||
| Crystallographic refinement of interleukin 1 beta at 2.0 A resolution | Q24601516 | ||
| Keratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammation | Q24673428 | ||
| Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta | Q27734947 | ||
| A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist | Q27734950 | ||
| How to measure and predict the molar absorption coefficient of a protein | Q27860551 | ||
| IL1HY1: A novel interleukin-1 receptor antagonist gene | Q28116196 | ||
| A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes | Q28237565 | ||
| Three-Dimensional Structures of Acidic and Basic Fibroblast Growth Factors | Q28267322 | ||
| Cloning of a new cytokine that induces IFN-gamma production by T cells | Q28283928 | ||
| The interleukin 1 receptor: ligand interactions and signal transduction | Q28295124 | ||
| Structure and expression of the mRNA encoding a novel fibroblast growth factor, FGF-18 | Q28582688 | ||
| Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme | Q28610362 | ||
| Genomic organization of the human fibroblast growth factor receptor 2 (FGFR2) gene and comparative analysis of the human FGFR gene family | Q30669080 | ||
| Fibroblast growth factor receptors (FGFRs) and their roles in limb development | Q33592059 | ||
| Formation of an active dimer during storage of interleukin-1 receptor antagonist in aqueous solution | Q34041339 | ||
| Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen | Q34293620 | ||
| Expression of ST2, an interleukin-1 receptor homologue, is induced by proinflammatory stimuli | Q34431061 | ||
| Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1. | Q36353242 | ||
| Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone. | Q36366486 | ||
| cDNA cloning of an intracellular form of the human interleukin 1 receptor antagonist associated with epithelium | Q37494553 | ||
| Complement component C3b binds directly to purified glycoprotein C of herpes simplex virus types 1 and 2. | Q38348319 | ||
| Acute and Recurrent Infection with Herpes Simplex Virus in the Mouse: a Model for Studying Latency and Recurrent Disease | Q39953233 | ||
| Human keratinocytes produce but do not process pro-interleukin-1 (IL-1) beta. Different strategies of IL-1 production and processing in monocytes and keratinocytes | Q40512221 | ||
| Resistance to fever induction and impaired acute-phase response in interleukin-1 beta-deficient mice | Q40682982 | ||
| ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. | Q41270104 | ||
| A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor | Q42834513 | ||
| In vivo production of cytokines and beta (C-C) chemokines in human recurrent herpes simplex lesions--do herpes simplex virus-infected keratinocytes contribute to their production? | Q45756899 | ||
| Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants | Q47759209 | ||
| Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4. | Q47840782 | ||
| Overview of interleukin-18: more than an interferon-gamma inducing factor | Q47992381 | ||
| Activation of the IL-1 Gene in UV-Irradiated Mouse Skin: Association with Inflammatory Sequelae and Pharmacologic Intervention | Q68266389 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| cell-cell signaling | Q14758911 | ||
| Interleukin 36 beta | Q21113432 | ||
| Interleukin 36 gamma | Q21113433 | ||
| Interleukin 37 | Q21116079 | ||
| Interleukin 36A | Q21495892 | ||
| P304 | page(s) | 10308-14 | |
| P577 | publication date | 2000-04-07 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Identification and initial characterization of four novel members of the interleukin-1 family | |
| P478 | volume | 275 |
| Q33186130 | A bicistronic expression system for bacterial production of authentic human interleukin-18. |
| Q24536244 | A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity |
| Q28189011 | A new nomenclature for IL-1-family genes |
| Q39443387 | A whole genome screen for HIV restriction factors |
| Q36303652 | ATP induces protein arginine deiminase 2-dependent citrullination in mast cells through the P2X7 purinergic receptor |
| Q38631469 | Allergic airway inflammation: unravelling the relationship between IL-37, IL-18Rα and Tir8/SIGIRR. |
| Q64110826 | An innate interaction between IL-18 and the propeptide that inactivates its precursor form |
| Q28679180 | Annotating genes with potential roles in the immune system: six new members of the IL-1 family |
| Q33923398 | Anorexia of infection: current prospects |
| Q55514829 | Anti-Allergic Inflammatory Activity of Interleukin-37 Is Mediated by Novel Signaling Cascades in Human Eosinophils. |
| Q34081822 | Anti-inflammatory effect of IL-37b in children with allergic rhinitis |
| Q39268368 | Association of IL-37 gene polymorphisms with susceptibility to tuberculosis in Saudi subjects. |
| Q47912332 | Biology of IL-38 and its role in disease |
| Q45898977 | Biomarkers in inflammatory bowel diseases: insight into diagnosis, prognosis and treatment. |
| Q64238214 | Cathepsin G cleaves and activates IL-36γ and promotes the inflammation of psoriasis |
| Q89911986 | Chloroquine and Rapamycin Augment Interleukin-37 Expression via the LC3, ERK, and AP-1 Axis in the Presence of Lipopolysaccharides |
| Q37314750 | Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus |
| Q28208057 | Cloning and characterization of IL-1HY2, a novel interleukin-1 family member |
| Q24303608 | Cloning, expression, and initial characterization of a novel cytokine-like gene family |
| Q40421570 | Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis |
| Q28570754 | Copper chelation represses the vascular response to injury |
| Q33762424 | Correlation between IL36α and IL17 and Activity of the Disease in Selected Autoimmune Blistering Diseases |
| Q28190084 | Cytokines and acute neurodegeneration |
| Q28255491 | Cytokines in psoriasis |
| Q42505905 | DIRA, DITRA, and new insights into pathways of skin inflammation: what's in a name? |
| Q34733339 | Decreased expression of interleukin-36α predicts poor prognosis in colorectal cancer patients |
| Q92247111 | Designed DNA-Encoded IL-36 Gamma Acts as a Potent Molecular Adjuvant Enhancing Zika Synthetic DNA Vaccine-Induced Immunity and Protection in a Lethal Challenge Model |
| Q44566982 | Differential expression and haplotypic variation of two interleukin-1beta genes in the common carp (Cyprinus carpio L.). |
| Q92971145 | Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation |
| Q37587376 | Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration |
| Q37222623 | Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barré syndrome |
| Q40424694 | Elevated serum interleukin-37 level is a predictive biomarker of poor prognosis in epithelial ovarian cancer patients |
| Q28397770 | Epithelial expression of interleukin-37b in inflammatory bowel disease |
| Q24291684 | Evidence that HAX-1 is an interleukin-1 alpha N-terminal binding protein |
| Q34980877 | Evolution of interleukin-1beta |
| Q33789826 | Exogenous interleukin 37 ameliorates atherosclerosis via inducing the Treg response in ApoE-deficient mice |
| Q36064065 | Expression and Regulation of Interleukin-37 in Pathogenesis of Nasal Polyps |
| Q36100192 | Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells |
| Q92191072 | Function and Regulation of IL-36 Signaling in Inflammatory Diseases and Cancer Development |
| Q34401934 | Functional role played by the glycosylphosphatidylinositol anchor glycan of CD48 in interleukin-18-induced interferon-gamma production |
| Q34526913 | Gene therapy for rheumatoid arthritis. Lessons from animal models, including studies on interleukin-4, interleukin-10, and interleukin-1 receptor antagonist as potential disease modulators |
| Q39321475 | Generalized pustular psoriasis with a novel mutation of interleukin-36 receptor antagonist, responding to methotrexate |
| Q37633533 | Genomic Variant in IL-37 Confers A Significant Risk of Coronary Artery Disease. |
| Q33241218 | Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo |
| Q57079372 | Homodimerization attenuates the anti-inflammatory activity of interleukin-37 |
| Q36005876 | IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance |
| Q34144622 | IL-1 family nomenclature |
| Q24620194 | IL-1F5, -F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression |
| Q48284889 | IL-1Rrp2 expression and IL-1F9 (IL-1H1) actions in brain cells |
| Q64080513 | IL-36 Cytokines: Regulators of Inflammatory Responses and Their Emerging Role in Immunology of Reproduction |
| Q64098559 | IL-36, IL-37, and IL-38 Cytokines in Skin and Joint Inflammation: A Comprehensive Review of Their Therapeutic Potential |
| Q34430063 | IL-36α exerts pro-inflammatory effects in the lungs of mice |
| Q42054286 | IL-36α: a novel cytokine involved in the catabolic and inflammatory response in chondrocytes. |
| Q37014472 | IL-36γ Augments Host Defense and Immune Responses in Human Female Reproductive Tract Epithelial Cells |
| Q40340613 | IL-36γ is a crucial proximal component of protective type-1-mediated lung mucosal immunity in Gram-positive and -negative bacterial pneumonia |
| Q41768407 | IL-36γ is secreted in microparticles and exosomes by lung macrophages in response to bacteria and bacterial components |
| Q39253966 | IL-36γ/IL-1F9, an innate T-bet target in myeloid cells. |
| Q41161964 | IL-37 Expression is Upregulated in Patients with Tuberculosis and Induces Macrophages Towards an M2-like Phenotype |
| Q38957793 | IL-37 inhibits IL-18-induced tubular epithelial cell expression of pro-inflammatory cytokines and renal ischemia-reperfusion injury |
| Q28295265 | IL-37 is a fundamental inhibitor of innate immunity |
| Q54941074 | IL-37 isoform D downregulates pro-inflammatory cytokines expression in a Smad3-dependent manner. |
| Q54325530 | IL-37 protects against obesity-induced inflammation and insulin resistance. |
| Q99552874 | IL-37: An anti-inflammatory cytokine with antitumor functions |
| Q53460275 | IL-37b suppresses T cell priming by modulating dendritic cell maturation and cytokine production via dampening ERK/NF-κB/S6K signalings. |
| Q92455239 | IL-38: A New Player in Inflammatory Autoimmune Disorders |
| Q38292971 | Identification of amino acid residues critical for biological activity in human interleukin-18. |
| Q34308222 | Immune surveillance in the skin: mechanisms and clinical consequences |
| Q36130481 | Immunobiology of IL-37: mechanism of action and clinical perspectives |
| Q38537820 | Immunoregulatory Pathways Involved in Inflammatory Bowel Disease. |
| Q92154588 | In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod |
| Q58694432 | In vivo expression of interleukin-37 reduces local and systemic inflammation in concanavalin A-induced hepatitis |
| Q34196219 | Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells |
| Q84865125 | Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis |
| Q26745577 | Interactions between Autophagy and Inhibitory Cytokines |
| Q28239808 | Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs |
| Q34095673 | Interleukin 18 in the CNS. |
| Q57487601 | Interleukin 30 to Interleukin 40 |
| Q35289509 | Interleukin 37 expression protects mice from colitis |
| Q38908298 | Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia |
| Q40573249 | Interleukin-1 homologues IL-1F7b and IL-18 contain functional mRNA instability elements within the coding region responsive to lipopolysaccharide |
| Q36194613 | Interleukin-1 polymorphisms and graft-vs-host disease |
| Q43061584 | Interleukin-18 treatment options for inflammatory diseases |
| Q40666192 | Interleukin-1beta responses to Mycoplasma pneumoniae infection are cell-type specific |
| Q24630062 | Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity |
| Q64892752 | Interleukin-36 in Infectious and Inflammatory Skin Diseases. |
| Q89566519 | Interleukin-36: Structure, Signaling and Function |
| Q33918535 | Interleukin-36β provides protection against HSV-1 infection, but does not modulate initiation of adaptive immune responses |
| Q41825896 | Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis. |
| Q89338769 | Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice |
| Q36252429 | Interleukin-37 reduces liver inflammatory injury via effects on hepatocytes and non-parenchymal cells |
| Q36485477 | Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer |
| Q52649775 | Interleukin-37: A crucial cytokine with multiple roles in disease and potentially clinical therapy. |
| Q61802937 | Interleukin-37: The Effect of Anti-Inflammatory Response in Human Coronary Artery Endothelial Cells |
| Q38686666 | Interleukin-37: a new molecular target for host-directed therapy of tuberculosis |
| Q47652910 | Intracellular mature IL-37 suppresses tumor metastasis via inhibiting Rac1 activation |
| Q47654931 | Macrophage-Specific Expression of IL-37 in Hyperlipidemic Mice Attenuates Atherosclerosis |
| Q35870730 | Mannose-capped Lipoarabinomannan from Mycobacterium tuberculosis induces IL-37 production via upregulating ERK1/2 and p38 in human type II alveolar epithelial cells. |
| Q34963658 | Microglia as a source and target of cytokines |
| Q34693390 | Neuroendocrine-immune interactions in fish: a role for interleukin-1. |
| Q36994761 | Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease |
| Q24676343 | Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation |
| Q47285878 | Overview of the IL-1 family in innate inflammation and acquired immunity |
| Q92637366 | Parsing the IL-37-Mediated Suppression of Inflammasome Function |
| Q38638181 | Plasma IL-37 Elevated in Patients with Chronic Heart Failure and Predicted Major Adverse Cardiac Events: A 1-Year Follow-Up Study. |
| Q36289982 | Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death |
| Q47946597 | Polymorphic light eruption and IL-1 family members: any difference with allergic contact dermatitis? |
| Q55070768 | Reviews of Interleukin-37: Functions, Receptors, and Roles in Diseases. |
| Q35250392 | Role of IL-38 and its related cytokines in inflammation |
| Q55489605 | Role of Interleukin-38 in Chronic Inflammatory Diseases: A Comprehensive Review. |
| Q37980914 | Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver |
| Q24301821 | S100A13 mediates the copper-dependent stress-induced release of IL-1α from both human U937 and murine NIH 3T3 cells |
| Q58613929 | Scoping Review on Use of Drugs Targeting Interleukin 1 Pathway in DIRA and DITRA |
| Q34158166 | Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family |
| Q34408962 | Suppression of antigen-specific adaptive immunity by IL-37 via induction of tolerogenic dendritic cells |
| Q48105627 | Suppression of inflammation and acquired immunity by IL-37. |
| Q37213297 | Suppression of innate inflammation and immunity by interleukin-37. |
| Q37820911 | Targeting the IL-1 family members in skin inflammation. |
| Q33765926 | The Effect of Interleukin 38 on Angiogenesis in a Model of Oxygen-induced Retinopathy |
| Q26752849 | The IL-1 cytokine family and its role in inflammation and fibrosis in the lung |
| Q90084199 | The IL-1 family of cytokines and receptors in rheumatic diseases |
| Q30152709 | The Role of IL-37 in Non-Cancerous Diseases. |
| Q54688502 | The balance between pro- and anti-inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL-1 family members. |
| Q37516563 | The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases |
| Q35888523 | The double-stranded RNA analogue polyinosinic-polycytidylic acid induces keratinocyte pyroptosis and release of IL-36γ. |
| Q36859216 | The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders |
| Q50970356 | The majority of generalized pustular psoriasis without psoriasis vulgaris is caused by deficiency of interleukin-36 receptor antagonist. |
| Q21195661 | The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes |
| Q30152777 | The role of IL-37 in cancer. |
| Q36903300 | The severity of experimental arthritis is independent of IL-36 receptor signaling |
| Q27642289 | The structure and binding mode of interleukin-18 |
| Q39947182 | Therapeutic effect of neutralizing endogenous IL-18 activity in the collagen-induced model of arthritis |
| Q35519210 | Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. |
| Q35289513 | Transfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer. |
Search more.